Publication | Open Access

The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals

Pegylated InterferonRibavirin TherapyViral HepatitisImmunologyAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapyChronic Hcv InfectionChronic Viral InfectionAntiviral DrugHivMedicine